ROR1 and melanoma: IHC analyses have demonstrated a wide-spread expression of ROR1 across many tumor entities with significantly higher expression levels in cancerous than in adjacent normal tissue (Table 1), including a particularly strong expression in melanoma, colon, pancreatic, lung, and breast cancer [22,41,56].